Effects of Creatine and Heat Exposure on Exercise Performance and Body Water Distribution

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-27
SponsorUniversity of Windsor

About this trial

The goal of this clinical trial is to learn whether creatine supplementation changes how the body adapts to repeated exercise in the heat in healthy recreationally active adults and varsity athletes. The study will also examine whether creatine affects fluid balance, blood volume changes and exercise performance.

The main questions it aims to answer are:

Does creatine supplementation increase plasma volume and total body water during repeated heat exposure more than placebo? Does creatine supplementation improve exercise performance after heat acclimation more than placebo? Does creatine supplementation influence cardiovascular responses to heat stress?

Researchers will compare a creatine supplementation group to a placebo group to determine whether creatine changes the magnitude of heat acclimation adaptations.

Participants will:

Complete baseline measurements of body composition, hydration, blood markers, and exercise performance.

Consume either creatine monohydrate or a placebo supplement daily Complete repeated supervised exercise sessions in a controlled heated environment Undergo repeated assessments of body water, temperature, heart rate, and exercise performance throughout the study

Eligibility criteria

Qualifiers

Healthy biological males between 18 and 27 years of age

Recreationally active males and varsity athletes

Able to safely participate in moderate-intensity exercise and heat exposure

Willing to maintain habitual diet and physical activity throughout the study

Disqualifiers

History of cardiovascular, metabolic, respiratory, renal, neurological, or heat-related illness

Contraindications to exercise testing or heat exposure identified during health screening

Current musculoskeletal injury limiting exercise participation

Current use of creatine supplementation or inability to complete the required washout period

Trial design

Treatments tested in this trial

  • Creatine Monohydrate
  • Maltodextrin (Placebo)

Treatment groups

25 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators